[CLINICAL STUDY OF A LIPOTROPIC FORMULA: ORNITAINE].
D000470:Alkaloids; D001161:Arteriosclerosis; D002763:Cholecystectomy; D002784:Cholesterol / Q000097:blood*; D002951:Citrates; D008055:Lipids / Q000097:blood*; D008074:Lipoproteins; D008082:Lipotropic Agents; D008107:Liver Diseases; D008274:Magnesium; D009952:Ornithine; D011183:Postoperative Complications; D011736:Pyridoxine; D013012:Sorbitol; D014116:Toxicology
D000470:Alkaloids; D002951:Citrates; D008055:Lipids; D008074:Lipoproteins; D008082:Lipotropic Agents; D013012:Sorbitol; D002784:Cholesterol; D009952:Ornithine; D008274:Magnesium; D011736:Pyridoxine
ALKALOIDS; ARTERIOSCLEROSIS; BLOOD CHOLESTEROL; BLOOD LIPIDS; CHOLECYSTECTOMY; CITRATES; LIPOPROTEINS; LIVER DISEASES; MAGNESIUM; ORNITHINE; POSTOPERATIVE COMPLICATIONS; PYRIDOXINE; SORBITOL; TOXICOLOGIC REPORT
ETUDE CLINIQUE D'UNE FORMULE LIPOTROPE: L'ORNITAUINE.